125 related articles for article (PubMed ID: 12036949)
1. Identification of differentially expressed genes in normal and malignant prostate by electronic profiling of expressed sequence tags.
Asmann YW; Kosari F; Wang K; Cheville JC; Vasmatzis G
Cancer Res; 2002 Jun; 62(11):3308-14. PubMed ID: 12036949
[TBL] [Abstract][Full Text] [Related]
2. Cysteine-rich secretory protein-3: a potential biomarker for prostate cancer.
Kosari F; Asmann YW; Cheville JC; Vasmatzis G
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1419-26. PubMed ID: 12433721
[TBL] [Abstract][Full Text] [Related]
3. GDEP, a new gene differentially expressed in normal prostate and prostate cancer.
Olsson P; Bera TK; Essand M; Kumar V; Duray P; Vincent J; Lee B; Pastan I
Prostate; 2001 Sep; 48(4):231-41. PubMed ID: 11536302
[TBL] [Abstract][Full Text] [Related]
4. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
Chakrabarti R; Robles LD; Gibson J; Muroski M
Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
[TBL] [Abstract][Full Text] [Related]
5. Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array.
Chetcuti A; Margan S; Mann S; Russell P; Handelsman D; Rogers J; Dong Q
Prostate; 2001 May; 47(2):132-40. PubMed ID: 11340636
[TBL] [Abstract][Full Text] [Related]
6. Cysteine-rich secretory protein 3 plays a role in prostate cancer cell invasion and affects expression of PSA and ANXA1.
Pathak BR; Breed AA; Apte S; Acharya K; Mahale SD
Mol Cell Biochem; 2016 Jan; 411(1-2):11-21. PubMed ID: 26369530
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer expression profiling by cDNA sequencing analysis.
Huang GM; Ng WL; Farkas J; He L; Liang HA; Gordon D; Yu J; Hood L
Genomics; 1999 Jul; 59(2):178-86. PubMed ID: 10409429
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjögren's syndrome.
Tapinos NI; Polihronis M; Thyphronitis G; Moutsopoulos HM
Arthritis Rheum; 2002 Jan; 46(1):215-22. PubMed ID: 11817594
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition mediated by PSP94 or CRISP-3 is prostate cancer cell line specific.
Pathak BR; Breed AA; Nakhawa VH; Jagtap DD; Mahale SD
Asian J Androl; 2010 Sep; 12(5):677-89. PubMed ID: 20676114
[TBL] [Abstract][Full Text] [Related]
10. PRAC: A novel small nuclear protein that is specifically expressed in human prostate and colon.
Liu XF; Olsson P; Wolfgang CD; Bera TK; Duray P; Lee B; Pastan I
Prostate; 2001 May; 47(2):125-31. PubMed ID: 11340635
[TBL] [Abstract][Full Text] [Related]
11. Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer.
Waghray A; Schober M; Feroze F; Yao F; Virgin J; Chen YQ
Cancer Res; 2001 May; 61(10):4283-6. PubMed ID: 11358857
[TBL] [Abstract][Full Text] [Related]
12. [High throughput screening and analysis of prostate cancer-related genes through mining databases].
Wu G; Peng L; Jin FS; Li QS
Ai Zheng; 2006 May; 25(5):645-50. PubMed ID: 16687091
[TBL] [Abstract][Full Text] [Related]
13. Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells.
Kim JM; Sohn HY; Yoon SY; Oh JH; Yang JO; Kim JH; Song KS; Rho SM; Yoo HS; Kim YS; Kim JG; Kim NS
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):473-82. PubMed ID: 15701830
[TBL] [Abstract][Full Text] [Related]
14. Characterization and comparative analyses of transcriptomes from the normal and neoplastic human prostate.
Clegg N; Abbott D; Ferguson C; Coleman R; Nelson PS
Prostate; 2004 Aug; 60(3):227-39. PubMed ID: 15176052
[TBL] [Abstract][Full Text] [Related]
15. Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer.
Hoogland AM; Böttcher R; Verhoef E; Jenster G; van Leenders GJ
Oncotarget; 2016 Jun; 7(25):37846-37856. PubMed ID: 27191985
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
[TBL] [Abstract][Full Text] [Related]
17. Ventral prostate predominant l, a novel mouse gene expressed exclusively in the prostate.
Wubah JA; Fischer CM; Rolfzen LN; Khalili M; Kang J; Green JE; Bieberich CJ
Prostate; 2002 Apr; 51(1):21-9. PubMed ID: 11920954
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatic screening of human ESTs for differentially expressed genes in normal and tumor tissues.
Aouacheria A; Navratil V; Barthelaix A; Mouchiroud D; Gautier C
BMC Genomics; 2006 Apr; 7():94. PubMed ID: 16640784
[TBL] [Abstract][Full Text] [Related]
19. Novel biomarkers for prostate cancer including noncoding transcripts.
Romanuik TL; Ueda T; Le N; Haile S; Yong TM; Thomson T; Vessella RL; Sadar MD
Am J Pathol; 2009 Dec; 175(6):2264-76. PubMed ID: 19893039
[TBL] [Abstract][Full Text] [Related]
20. Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle.
Thompson M; Lapointe J; Choi YL; Ong DE; Higgins JP; Brooks JD; Pollack JR
Prostate; 2008 Aug; 68(11):1248-56. PubMed ID: 18500686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
